Document/ExhibitDescriptionPagesSize 1: 10-Q Quarterly Report HTML 907K
2: EX-10.11 Material Contract HTML 22K
3: EX-31.1 Certification -- §302 - SOA'02 HTML 23K
4: EX-31.2 Certification -- §302 - SOA'02 HTML 23K
5: EX-32.1 Certification -- §906 - SOA'02 HTML 21K
12: R1 Cover Page HTML 75K
13: R2 Condensed Consolidated Balance Sheet (Unaudited) HTML 132K
14: R3 Condensed Consolidated Balance Sheet (Unaudited) HTML 28K
(Parenthetical)
15: R4 Condensed Consolidated Statement of Operations HTML 115K
(Unaudited)
16: R5 Condensed Consolidated Statement of Cash Flows HTML 107K
(Unaudited)
17: R6 Condensed Consolidated Statement of Stockholders' HTML 79K
Equity (Unaudited)
18: R7 Condensed Consolidated Statement of Stockholders' HTML 22K
Equity (Unaudited) (Parenthetical)
19: R8 Financial Statement Presentation HTML 24K
20: R9 Acquisitions HTML 24K
21: R10 Properties and Equipment, Net HTML 31K
22: R11 Debt and Credit Agreements HTML 34K
23: R12 Derivative Instruments HTML 177K
24: R13 Fair Value Measurements HTML 89K
25: R14 Asset Retirement Obligations HTML 28K
26: R15 Commitments and Contingencies HTML 33K
27: R16 Revenue Recognition HTML 37K
28: R17 Capital Stock HTML 28K
29: R18 Stock-Based Compensation HTML 47K
30: R19 Employee Benefit Plans HTML 23K
31: R20 Earnings per Common Share HTML 40K
32: R21 Additional Balance Sheet Information HTML 64K
33: R22 Financial Statement Presentation (Policies) HTML 22K
34: R23 Properties and Equipment, Net (Tables) HTML 30K
35: R24 Debt and Credit Agreements (Tables) HTML 33K
36: R25 Derivative Instruments (Tables) HTML 205K
37: R26 Fair Value Measurements (Tables) HTML 87K
38: R27 Asset Retirement Obligations (Tables) HTML 28K
39: R28 Revenue Recognition (Tables) HTML 32K
40: R29 Stock-Based Compensation (Tables) HTML 36K
41: R30 Earnings per Common Share (Tables) HTML 42K
42: R31 Additional Balance Sheet Information (Tables) HTML 63K
43: R32 Acquisitions (Details) HTML 29K
44: R33 Properties and Equipment, Net (Details) HTML 37K
45: R34 Debt and Credit Agreements - Schedule of Debt HTML 40K
(Details)
46: R35 Debt and Credit Agreements - Narrative (Details) HTML 43K
47: R36 Derivative Instruments - Outstanding Commodity HTML 181K
Derivatives (Details)
48: R37 Derivative Instruments - Effect of Derivative HTML 34K
Instruments on the Condensed Consolidated Balance
Sheet (Details)
49: R38 Derivative Instruments - Offsetting of Derivative HTML 51K
Assets and Liabilities in the Condensed
Consolidated Balance Sheet (Details)
50: R39 Derivative Instruments - Effect of Derivative HTML 26K
Instruments on the Condensed Consolidated
Statement of Operations (Details)
51: R40 Fair Value Measurements - Financial Assets and HTML 51K
Liabilities, Recurring (Details)
52: R41 Fair Value Measurements - Reconciliation of HTML 33K
Changes in Fair Value of Financial Assets and
Liabilities (Details)
53: R42 Fair Value Measurements - Narrative (Details) HTML 21K
54: R43 Fair Value Measurements - Fair Value of Other HTML 33K
Financial Instruments (Details)
55: R44 Asset Retirement Obligations (Details) HTML 33K
56: R45 Revenue Recognition - Disaggregation of Revenue HTML 29K
(Details)
57: R46 Revenue Recognition - Narrative (Details) HTML 34K
58: R47 Capital Stock (Details) HTML 39K
59: R48 Stock-Based Compensation - Narrative (Details) HTML 136K
60: R49 Stock-Based Compensation - Assumptions Used to HTML 41K
Determine Grant Date Fair Value of Equity and
Liability Component (Details)
61: R50 Stock-Based Compensation - Assumptions for TSR HTML 34K
Shares (Details)
62: R51 Employee Benefit Plans (Details) HTML 22K
63: R52 Earnings per Common Share - Schedule of EPS HTML 27K
(Details)
64: R53 Earnings per Common Share - Calculation of HTML 28K
Weighted-Average Shares Excluded from Diluted EPS
(Details)
65: R54 Additional Balance Sheet Information (Details) HTML 87K
67: XML IDEA XML File -- Filing Summary XML 120K
11: XML XBRL Instance -- cog-20210930_htm XML 2.03M
66: EXCEL IDEA Workbook of Financial Reports XLSX 78K
7: EX-101.CAL XBRL Calculations -- cog-20210930_cal XML 191K
8: EX-101.DEF XBRL Definitions -- cog-20210930_def XML 453K
9: EX-101.LAB XBRL Labels -- cog-20210930_lab XML 1.36M
10: EX-101.PRE XBRL Presentations -- cog-20210930_pre XML 771K
6: EX-101.SCH XBRL Schema -- cog-20210930 XSD 137K
68: JSON XBRL Instance as JSON Data -- MetaLinks 343± 490K
69: ZIP XBRL Zipped Folder -- 0000858470-21-000060-xbrl Zip 263K
(Address of principal executive offices, including ZIP code)
(i281) i589-4600
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
iCommon
Stock, par value $0.10 per share
iCTRA
iNew York Stock Exchange
Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. iYes☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data
File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). iYes☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company,
or an emerging growth company. See the definitions of “large accelerated filer,”“accelerated filer,”“smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
iLarge accelerated filer
☒
Accelerated
filer
☐
Non-accelerated filer
☐
Smaller reporting company
i☐
Emerging
growth company
i☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the
registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes i☐ No ☒
As of November 1, 2021, there were i813,577,639
shares of Common Stock, Par Value $0.10 Per Share, outstanding.
On October 1, 2021, Cabot Oil & Gas Corporation (“Cabot”) completed its previously announced merger transaction involving Cimarex Energy Co. (“Cimarex”) pursuant to which a wholly owned subsidiary of Cabot merged with and into Cimarex, with Cimarex surviving the merger as a subsidiary of Cabot (the “Merger”). After the Merger, Cabot changed its name to Coterra Energy Inc. (“Coterra” or the “Company”).
Although this Quarterly Report on Form 10-Q is filed after the completion of the Merger, unless otherwise specifically noted herein, information set forth herein only relates to the period as of and for the quarter and year-to-date
periods ended September 30, 2021 and therefore does not include the information of Cimarex for those periods. Accordingly, unless otherwise specifically noted herein, references herein to Coterra, the Company, we, us, or our refer only to Coterra and its subsidiaries prior to the Merger and do not include Cimarex and its subsidiaries.
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
1. iFinancial
Statement Presentation
On October 1, 2021, Cabot Oil & Gas Corporation changed its name to Coterra Energy Inc. (the “Company” or “Coterra”) in connection with the Merger (defined below) involving Cimarex Energy Co. (“Cimarex”) described below.
iDuring interim periods, the Company follows the same accounting policies disclosed in its Annual Report on Form 10-K for the year ended
December 31, 2020 (the “Form 10-K”) filed with the Securities and Exchange Commission (“SEC”), except for any new accounting pronouncements adopted during the period. The interim financial statements should be read in conjunction with the notes to the consolidated financial statements and information presented in the Form 10-K. In management’s opinion, the accompanying interim condensed consolidated financial statements contain all material adjustments, consisting only of normal recurring adjustments, necessary for a fair statement. The results for any interim period are not necessarily indicative of the results that may be expected for the entire year.
2. iAcquisitions
Merger
with Cimarex Energy Co.
On May 23, 2021, the Company entered into an Agreement and Plan of Merger (as amended as of June 29, 2021, the “Merger Agreement”) with Cimarex to combine via a merger transaction pursuant to which a wholly owned subsidiary of Cabot merged with and into Cimarex, with Cimarex surviving the merger as a subsidiary of Cabot (“Merger”). The respective Boards of Directors of the Company and Cimarex unanimously approved the Merger in May 2021, proposals related to the Merger were approved by stockholders of the
Company and Cimarex on September 29, 2021, and the Merger was completed on October 1, 2021. Cimarex is an oil and gas exploration and production company with operations in Texas, New Mexico and Oklahoma.
The Company issued approximately i408.2 million
shares of its common stock to Cimarex stockholders under terms of the Merger Agreement (excluding restricted shares that were awarded in replacement of previously outstanding Cimarex restricted share awards). Under the terms of the Merger Agreement, subject to certain exceptions, each share of Cimarex common stock was converted into the right to receive i4.0146 shares of common stock of the Company. Based on the closing price of Coterra's common stock on October
1, 2021, the total value of such shares of Coterra common stock was approximately $i9.1 billion.
The transaction is being accounted for using the acquisition method of accounting, with the Company being treated as the accounting acquirer. Under the acquisition method of accounting, the assets, liabilities and mezzanine equity of Cimarex and its subsidiaries
will be recorded at their respective fair values as of the date of the completion of the Merger. The preliminary purchase price allocation is not complete as of the date of this report and will be an ongoing process for up to one year subsequent to the closing date of the Merger. Determining the fair value of the assets and liabilities of Cimarex requires judgment and certain assumptions to be made, the most significant of these being related to the valuation of Cimarex's oil and gas properties. The Merger was structured as a tax-free reorganization for United States federal income tax purposes.
The post-acquisition results of operations of Cimarex for the fourth quarter of 2021 will be included in the Company's consolidated results for the period ending December 31, 2021.
3.
iProperties and Equipment, Net
iProperties and equipment, net are comprised of the following:
Accumulated
depreciation, depletion and amortization
(i3,430,882)
(i3,166,394)
$
i4,225,914
$
i4,044,606
/
At
September 30, 2021, the Company did not have any projects with exploratory well costs capitalized for a period of greater than ione year after drilling.
(1)Includes
$i88.0 million of current portion of long-term debt at December 31, 2020, which the Company repaid in January 2021.
(2)Includes $ii100.0/
million of current portion of long-term debt at December 31, 2020, which the Company repaid in September 2021.
/
At September 30, 2021, the Company was in compliance with all financial and other covenants applicable to its revolving credit facility and senior notes.
Revolving Credit Agreement
The borrowing base under the terms of the Company's revolving
credit facility was redetermined annually in April until the most recent amendment to the credit agreement in September 2021. Effective April 21, 2021, the borrowing base and available commitments were reaffirmed at $i3.2 billion and $i1.5
billion, respectively.
On June 17, 2021, the Company entered into an amendment to the credit agreement relating to its revolving credit facility to, among other things, (1) remove the requirement that certain of the Company’s restricted subsidiaries become guarantors under the credit agreement, (2) expand the permissible indebtedness that may be held or incurred by a restricted subsidiary and (3) make certain other changes to permit the Company and Cimarex to complete the Merger. This amendment became effective upon completion of the
Merger on October 1, 2021.
On September 16, 2021, the Company entered into another amendment to the credit agreement to, among other things: (1) remove the provisions which limited borrowings thereunder to an amount not to exceed the borrowing base and certain related provisions; (2) replace the then-existing financial maintenance covenants with a covenant requiring maintenance of a ratio of total debt to consolidated EBITDA of not more than i3.0
to 1.0; (3) provide that if, in the future, the Company no longer has any other indebtedness subject to a leverage-based financial maintenance covenant, then the leverage covenant shall be replaced by a covenant requiring maintenance of a ratio of total debt to total capitalization not to exceed 65 percent at any time; and (4) provide for changes to certain exceptions to the negative covenants to reflect the completion of the Merger. This amendment became effective upon completion of the Merger and closing of the debt exchange described below.
At September 30, 2021, the Company had ino
borrowings outstanding under its revolving credit facility and had unused commitments of $i1.5 billion.
Debt Exchange
Subsequent Event. On October 7, 2021 and after the completion of the Merger, the Company completed the exchange of $i1.8 billion
in aggregate principal of Cimarex senior notes (“Existing Cimarex Notes”) for $i1.8 billion in aggregate principal of new notes issued by Coterra (“New Coterra Notes”) and $i1.8 million
of cash consideration. In connection with the debt exchange, Cimarex obtained consents to adopt certain proposed amendments to each of the indentures governing the Existing Cimarex Notes to eliminate certain of the covenants, restrictive provisions and events of default from such indentures. The New Coterra Notes are general, unsecured, senior obligations of the Company and have substantially identical terms and covenants to the Existing Cimarex Notes (before giving effect to the amendments referred to in the immediately preceding sentence).
Effect of Derivative Instruments on the Condensed Consolidated Statement of Operations
Three
Months Ended September 30,
Nine Months Ended September 30,
(In thousands)
2021
2020
2021
2020
Cash received (paid) on settlement of derivative instruments
(Loss)
gain on derivative instruments
$
(i64,351)
$
i14,106
$
(i61,302)
$
i33,529
Non-cash
gain (loss) on derivative instruments
(Loss) gain on derivative instruments
(i136,931)
(i56,359)
(i240,339)
(i15,746)
$
(i201,282)
$
(i42,253)
$
(i301,641)
$
i17,783
/
6.
iFair Value Measurements
The Company follows the authoritative guidance for measuring fair value of assets and liabilities in its financial statements. For further information regarding the fair value hierarchy, refer to Note 1 of the Notes to the Consolidated Financial Statements in the Form 10-K.
Financial Assets and Liabilities
i
The
following fair value hierarchy table presents information about the Company’s financial assets and liabilities measured at fair value on a recurring basis:
(In thousands)
Quoted Prices in Active Markets for Identical Assets (Level 1)
The
Company's investments associated with its deferred compensation plan consist of mutual funds and deferred shares of the Company's common stock that are publicly traded and for which market prices are readily available.
The derivative instruments were measured based on quotes from the Company's counterparties or internal models. Such quotes and models have been derived using an income approach that considers various inputs, including current market and contractual prices for the underlying instruments, quoted forward commodity prices, basis differentials, volatility factors and interest rates for a similar length of time as the derivative contract term as applicable.
Estimates are derived from or verified using relevant NYMEX futures contracts and are compared to multiple quotes obtained from counterparties for reasonableness. The determination of the fair values presented above also incorporates a credit adjustment for non-performance risk. The
Company measured the non-performance risk of its counterparties by reviewing credit default swap spreads for the various financial institutions with which it has derivative transactions while non-performance
risk of the Company is evaluated using market credit spreads provided by several of the Company's banks. The Company has not incurred any losses related to non-performance risk of its counterparties and does not anticipate any material impact on its financial results due to non-performance by third parties.
The most significant unobservable inputs relative to the Company's Level 3 derivative contracts are volatility factors. An increase (decrease) in these unobservable inputs would result in an increase
(decrease) in fair value, respectively. The Company does not have access to the specific assumptions used in its counterparties’ valuation models. Consequently, additional disclosures regarding significant Level 3 unobservable inputs were not provided.
iThe following table sets forth a reconciliation of changes in the fair value of financial assets and
liabilities classified as Level 3 in the fair value hierarchy:
Nine Months Ended September 30,
(In thousands)
2021
2020
Balance at beginning of period
$
i23,562
$
(i22)
Total
gain (loss) included in earnings
(i222,387)
i2,866
Settlement
(gain) loss
i43,431
(i16,678)
Transfers
in and/or out of Level 3
i—
i—
Balance
at end of period
$
(i155,394)
$
(i13,834)
Change
in unrealized gains (losses) relating to assets and liabilities still held at the end of the period
$
(i156,642)
$
(i13,733)
/
Non-Financial
Assets and Liabilities
The Company discloses or recognizes its non-financial assets and liabilities, such as impairments or acquisitions, at fair value on a nonrecurring basis. As inone of the Company’s other non-financial assets and liabilities were measured at fair value as of September 30,
2021, additional disclosures were not required.
The estimated fair value of the Company’s asset retirement obligations at inception is determined by utilizing the income approach by applying a credit-adjusted risk-free rate, which takes into account the Company’s credit risk, the time value of money, and the current economic state to the undiscounted expected abandonment cash flows. Given the unobservable nature of the inputs, the measurement of the asset retirement obligations was classified as Level 3 in the fair value hierarchy.
Fair Value of Other Financial Instruments
The estimated fair value of other financial instruments is the amount at which the instruments
could be exchanged currently between willing parties. The carrying amounts reported in the Condensed Consolidated Balance Sheet for cash and cash equivalents and restricted cash approximate fair value, due to the short-term maturities of these instruments. Cash and cash equivalents and restricted cash are classified as Level 1 in the fair value hierarchy and the remaining financial instruments are classified as Level 2.
The Company uses available market data and valuation methodologies to estimate the fair value of debt. The fair value of debt is the estimated amount the Company would have to pay a third party to assume the debt, including a credit spread for the difference between the issue rate and the period end market rate. The credit spread is the
Company’s default or repayment risk. The credit spread (premium or discount) is determined by comparing the Company’s outstanding debt to new issuances and secondary trades of similar size and credit statistics for both public and private debt. The estimated fair value of the Company's outstanding debt is based on interest rates currently available to the Company. The Company’s debt is valued using an income approach and classified as Level 3 in the fair value hierarchy.
The Company has various contractual obligations in the normal course of its operations. There have been no material changes to the Company’s contractual obligations described under “Transportation and Gathering Agreements” and “Lease
Commitments” as disclosed in Note 9 of the Notes to Consolidated Financial Statements in the Form 10-K.
Legal Matters
Pennsylvania Office of Attorney General Matter
On June 16, 2020, the Office of Attorney General of the Commonwealth of Pennsylvania informed the Company that it will pursue certain misdemeanor and felony charges in a Susquehanna County Magisterial District Court against the Company related to alleged violations of the Pennsylvania Clean Streams Law, which prohibits discharge of industrial wastes. The Company is vigorously
defending itself against such charges; however, the proceedings could result in fines or penalties against the Company. At this time, it is not possible to estimate the amount of any fines or penalties, or the range of such fines or penalties, that are reasonably possible in this case.
Securities Litigation
In October 2020, a class action lawsuit styled Delaware County Emp. Ret. Sys. v. Cabot Oil and Gas Corp., et. al. (U.S. District Court, Middle District of Pennsylvania), was filed against the Company, Dan O. Dinges, its Chief Executive Officer, and Scott C. Schroeder, its Chief Financial
Officer, alleging that the Company made misleading statements in its periodic filings with the SEC in violation of Section 10(b) and Section 20 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). The plaintiffs allege misstatements in the Company’s public filings and disclosures over a number of years relating to its potential liability for alleged environmental violations in Pennsylvania. The plaintiffs allege that such misstatements caused a decline in the price of the Company’s common stock when it disclosed in its Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2019 two notices of violations from the Pennsylvania Department
of Environmental Protection and an additional decline when it disclosed on June 15, 2020 the criminal charges brought by the Office of the Attorney General of the Commonwealth of Pennsylvania related to alleged violations of the Pennsylvania Clean Streams Law, which prohibits discharge of industrial wastes. The court appointed Delaware County Employees Retirement System to represent the purported class on February 3, 2021. In April 2021, the complaint was amended to include Phillip L. Stalnaker, the Company’s Senior Vice President of Operations, as a defendant. The plaintiffs seek monetary damages, interest and attorney’s fees.
Also in October 2020, a stockholder derivative action styled Ezell v. Dinges, et. al. (U.S. District Court, Middle District of Pennsylvania), was filed against the Company, Messrs. Dinges and Schroeder and the Board of Directors of the Company, for alleged securities violations under Section 10(b) and Section 21D of the Exchange Act arising from the same alleged misleading statements that form the basis of the class action lawsuit described above. In addition to the Exchange Act claims, the derivative actions also allege claims based on breaches of fiduciary duty and statutory contribution theories.
On December 9, 2020, the Ezell case was consolidated with a second derivative case with similar allegations. In January 2021, a third derivative case was filed with substantially similar allegations and it too was consolidated with the Ezell case in February 2021.
On February 25, 2021, the Company filed a motion to transfer the class action lawsuit to the U.S. District Court for the Southern District of Texas, in Houston, Texas, where its headquarters are located. On June 11, 2021, the Company filed a motion to dismiss
the class action lawsuit on the basis that the plaintiffs’ allegations do not meet the requirements for pleading a claim under Section 10(b) or Section 20 of the Exchange Act. On June 22, 2021, the motion to transfer the class action lawsuit to the Southern District of Texas was granted. Pursuant to the prior agreement of the parties, the consolidated derivative case discussed in the preceding paragraph was also transferred to the Southern District of Texas on July 12, 2021. Subsequently, an additional stockholder derivative action styled Treppel Family Trust U/A 08/18/18 Lawrence A. Treppel and Geri D. Treppel for the benefit of Geri D. Treppel and Larry A. Treppel v. Dinges, et al. (U.S. District Court, Southern District of Texas, Houston Division), asserting substantially similar Delaware common law claims as in the existing
derivative cases, was filed in the Southern District of Texas and consolidated with the existing consolidated derivative cases. The motions to dismiss the class action lawsuit and the derivative actions are pending. The Company intends to vigorously defend the class action and derivative lawsuits.
In November 2020, the Company received a stockholder demand for inspection of books and records under Section 220 of the General Corporation Law of the State of Delaware (“Section 220 Demand”). The Section 220 Demand seeks broad categories of documents reviewed by the Board of Directors and minutes of meetings of the Board of Directors pertaining to alleged environmental violations in Pennsylvania, as well as documents relating to any board of directors conflicts
of interest, dating from January 1, 2015 to the present. The Company also received three other similar requests from other stockholders in February and June 2021. On May 17, 2021, the Company was served with a complaint filed in the Court of Chancery of the State of Delaware by the stockholder making the February 2021 Section 220 Demand to compel the production of books and records requested. After making an agreed books and records production, the Section 220 complaint was voluntarily dismissed effective September 21, 2021. The Company also provided substantially the same
books and records production in response to the other three Section 220 requests described above. It is possible that one or more additional stockholder suits could be filed pertaining to the subject matter of the Section 220 Demands and the class and derivative actions described above.
Other Legal Matters
The Company is a defendant in various other legal proceedings arising in the normal course of business. All known liabilities are accrued when management determines they are probable based on its best estimate of the potential loss. While the outcome and impact of these legal proceedings on the Company cannot be predicted with certainty, management believes that the resolution of these proceedings will not have
a material effect on the Company’s financial position, results of operations or cash flows.
Contingency Reserves
When deemed necessary, the Company establishes reserves for certain legal proceedings. The establishment of a reserve is based on an estimation process that includes the advice of legal counsel and subjective judgment of management. While management believes these reserves to be adequate, it is reasonably possible that the Company could incur additional losses with respect to those matters for which reserves have been established. The Company
believes that any such amount above the amounts accrued would not be material to the Condensed Consolidated Financial Statements. Future changes in facts and circumstances not currently known or foreseeable could result in the actual liability exceeding the estimated ranges of loss and amounts accrued.
iThe following table presents revenues from contracts with customers disaggregated by product:
Three
Months Ended September 30,
Nine Months Ended September 30,
(In thousands)
2021
2020
2021
2020
Natural gas
$
i641,625
$
i333,256
$
i1,526,202
$
i991,882
Other
i53
i38
i182
i181
$
i641,678
$
i333,294
$
i1,526,384
$
i992,063
/
All
of the Company’s revenues from contracts with customers represent products transferred at a point in time as control is transferred to the customer and generated in the United States of America.
Transaction Price Allocated to Remaining Performance Obligations
A significant number of the Company’s product sales contracts are short-term in nature, with a contract term of one year or less. For those contracts,
the Company has utilized the practical expedient exempting the Company from disclosure of the transaction price allocated to remaining performance obligations if the performance obligation is part of a contract that has an original expected duration of one year or less.
As of September 30, 2021, the Company had $i7.9
billion of unsatisfied performance obligations related to natural gas sales that have a fixed pricing component and a contract term greater than one year. The Company expects to recognize these obligations over periods ranging from two to i17 years.
Receivables from contracts with customers are recorded when the right to consideration becomes unconditional, which is generally when control of the product has been transferred to the customer. Receivables from contracts with customers were $i285.4 million and $i215.3
million as of September 30, 2021 and December 31, 2020, respectively, and are reported in accounts receivable, net on the Condensed Consolidated Balance Sheet. The Company currently has no assets or liabilities related to its revenue contracts, including no upfront payments or rights to deficiency payments.
10. iCapital
Stock
Issuance of Common Stock
On October 1, 2021 and upon closing the Merger, the Company issued approximately i408.2 million shares of its common stock to Cimarex stockholders under the terms of the Merger Agreement (excluding restricted shares that were awarded in replacement of previously outstanding Cimarex restricted share awards).
In April 2021, the Company’s Board of Directors approved an increase in the quarterly dividend on the Company's common stock from $i0.10
per share to $i0.11 per share.
Subsequent Event. On October 4, 2021, and in connection with the closing of the Merger, the Company’s Board of Directors approved a special dividend of $i0.50
per share payable on the Company’s common stock on October 22, 2021. On November 3, 2021, the Company’s Board of Directors approved an increase in the quarterly dividend on the Company's common stock from $i0.11 per share to
$i0.125 per share. Also on that date, related to the Company's dividend strategy to return at least 50 percent of quarterly free cash flows to stockholders, the Board of Directors approved a variable dividend of $i0.175
per share, for a total dividend of $i0.30 per share, payable on the Company’s common stock on November 24, 2021.
The Company grants certain stock-based compensation awards, including restricted stock awards, restricted stock units, performance share awards
and stock options. Stock-based compensation expense associated with these awards was $i10.3 million and $i11.4
million in the third quarters of 2021 and 2020, respectively, and $i26.3 million and $i36.0 million in the first
nine months of 2021 and 2020, respectively. Stock-based compensation expense is included in general and administrative expense in the Condensed Consolidated Statement of Operations.
Refer to Note 14 of the Notes to the Consolidated Financial Statements in the Form 10-K for further description of the various types of stock-based compensation awards and the applicable award terms.
Stock Options
Subsequent Event. On October 1, 2021, the Company granted stock option awards to purchase i1,577,554
shares of the Company’s common stock with exercise prices ranging from $i8.47 to $i28.72
per share. These awards are replacement awards granted to Cimarex employees and former employees as provided under the Merger Agreement and were fully vested on the closing date of the Merger. The grant date fair value of approximately $i14.6 million is expected to be recognized as merger consideration.
i
Fair
value was determined using a Black-Scholes option pricing model for in-the-money options and a Monte Carlo simulation model for out-of-the-money options based on the following assumptions:
In-the-money Options
Out-of-the-money Options
Assumptions:
Strike
price
$i8.47 - $i20.73
$i23.45
- $i28.72
Expected life
i1.9
- i3.1 years
i0.9
- i2.8 years
Expected volatility
i41.06%
- i45.77%
i38.44%
- i47.25%
Risk-free rate
i0.26%
- i0.50%
i0.08%
- i0.44%
/
Restricted Stock Awards
Subsequent Event. On October
1, 2021, the Company granted i3,364,354 shares of restricted stock, with a grant date value of $i22.25
per share. These awards are replacement awards granted to Cimarex employees as provided under the Merger Agreement. The fair value of these awards is measured based on the closing stock price on the closing date of the Merger (grant date). The awards will vest over periods ranging from itwo months to ithree
years. Approximately $i23.5 million of the grant date value is expected to be recognized as merger consideration and the remaining fair value will be recognized as stock-based compensation expense over the respective vesting periods.
Restricted Stock Units
Subsequent
Event. On September 30, 2021, certain executives of the Company entered into letter agreements whereby, in exchange for the cancellation of their rights under their change-in-control agreements and the non-competition and non-solicitation provisions contained in the letter agreements, each such executive would receive a grant of restricted stock units at the effective time of the Merger. On October 1, 2021, the Company granted i258,252
shares of restricted stock units, with a grant date value of $i22.25 per unit to each such executive. The fair value of these units is measured based on the closing stock price on the October 1, 2021 grant date and will fully vest over a isix-month
vesting period.
Restricted Stock Units - Non-Employee Directors
During the first nine months of 2021, the Company granted i107,156 restricted stock units, with a weighted-average grant date value of $i18.50
per unit, to the Company's non-employee directors. The fair value of these units is measured based on the closing stock price on the grant date and stock-based compensation expense is recorded immediately. These units immediately vest and are payable in shares of common stock of the Company when the director ceases to be a director of the Company.
Also during the first nine months of 2021, the Company issued i244,433
shares of common stock in connection with the vesting of restricted stock units with a weighted-average grant date value of $i14.08 upon the retirement of ione
of the Company's non-employee directors in the second quarter of 2021.
Subsequent Event. In October 2021, the Company issued i321,663
shares of common stock with a weighted-average grant date value of $i19.29 upon the resignation of ithree
of the Company's non-employee directors on the closing date of the Merger.
Performance Share Awards
The performance period for the awards granted by the Company during the first nine months of 2021 commenced on January 1, 2021 and ends on December 31, 2023. The Company used an annual forfeiture rate assumption ranging from izero
percent to ifour percent for purposes of recognizing stock-based compensation expense for its performance share awards.
Performance Share Awards Based on Internal Performance Metrics
The fair value of performance share award grants based on internal performance metrics is based on the closing stock price on the grant date. Each
performance share award represents the right to receive up to i100 percent of the award in shares of common stock. Based on the Company’s probability assessment at September 30, 2021, it is considered probable that the criteria for all performance awards based on internal
metrics awards will be met.
Employee Performance Share Awards. During the first nine months of 2021, the Company granted i696,280 Employee Performance Share Awards at a grant date value of $i18.58
per share. The 2021 awards are scheduled to vest i100 percent on the third anniversary of the grant date, provided that the Company averages $i100
million or more of operating cash flow during the ithree-year performance period, as set by the compensation committee of the Company's Board of Directors. If the Company does not meet the performance metric for the applicable performance period, then the performance shares that would have been issued on the anniversary date will be forfeited.
On
September 29, 2021, in accordance with the Merger Agreement, the compensation committee of the Board of Directors of the Company certified that the performance conditions of the Employee Performance Share Awards which were granted in 2019 had been met. These awards are expected to be issued and fully vested in the first quarter of 2022.
Hybrid Performance Share Awards. During the first nine months of 2021, the Company granted i423,171
Hybrid Performance Share Awards at a grant date value of $i18.58 per share. The 2021 awards are scheduled to vest ii25/
percent on each of the first and second anniversary of the grant date and i50 percent on the third anniversary of the grant date, provided that the Company has $i100
million or more of operating cash flow for the year preceding the vesting date, as set by the compensation committee of the Company's Board of Directors. If the Company does not meet the performance metric for the applicable period, then the portion of the performance shares that would have been issued on that anniversary date will be forfeited.
Subsequent Event. On October 1, 2021, in accordance with the Merger Agreement, the Company vested i960,497
shares of common stock in connection with the accelerated vesting of all outstanding Hybrid Performance Share Awards with a weighted-average grant date value of $i18.45 upon the completion of the Merger. The Company will recognize approximately $i7.6 million
of stock-based compensation expense in the fourth quarter of 2021 associated with the accelerated vesting of these awards.
Performance Share Awards Based on Market Conditions
These awards have both an equity and liability component, with the right to receive up to the first i100 percent of the award in shares of common stock and the
right to receive up to an additional i100 percent of the value of the award in excess of the equity component in cash. The equity portion of these awards is valued on the grant date and is not marked to market, while the liability portion of the awards is valued as of the end of each reporting period on a mark-to-market basis. The Company calculates
the fair value of the equity and liability portions of the awards using a Monte Carlo simulation model.
TSR Performance Share Awards. During the first nine months of 2021, the Company granted i723,224 TSR Performance Share Awards which
are earned, or not earned, based on the comparative performance of the Company’s common stock measured against a predetermined group of companies in the Company’s peer group over a ithree-year performance period. The Company incorporated a new feature in the 2021 TSR awards that will
reduce the potential cash component of the award if the actual performance is negative over the ithree-year period and the base calculation indicates an above-target payout.
iThe
following assumptions were used to determine the grant date fair value of the equity component on February 17, 2021 and the period-end fair value of the liability component of the TSR Performance Share Awards:
Subsequent Event. On October 1, 2021, in accordance with the Merger Agreement, the
Company vested i2,122,077 shares of common stock in connection with the accelerated vesting of all outstanding TSR Performance Share Awards with a weighted-average grant date value of $i16.30
upon the completion of the Merger. Under the terms of the Merger Agreement, all TSR Performance Share Awards were vested at target, resulting in a i100 percent payout of equity, with no cash payments earned under the awards. The Company will recognize approximately $i10.3 million
of stock-based compensation expense in the fourth quarter of 2021 associated with the acceleration of vesting of these awards.
12. iEmployee Benefit Plans
Deferred Compensation Plan
Subsequent Event. On September
30, 2021, certain executives of the Company entered into letter agreements whereby, in exchange for the cancellation of their rights under their change-in-control agreements and the non-competition and non-solicitation provisions contained in the letter agreements, each such executive would receive a contribution into his or her deferred compensation account at the effective time of the Merger. On October 1, 2021, the Company made deferred contribution payments totaling approximately $i19.3 million
into such executives’ deferred compensation accounts. All of such contributions are fully vested.
13. iEarnings per Common Share
Basic earnings per share (“EPS”) is computed by dividing net income by the weighted-average number of common shares outstanding for the period. Diluted EPS is similarly calculated, except that the common shares outstanding for the period is increased using
the treasury stock method to reflect the potential dilution that could occur if outstanding stock awards were vested at the end of the applicable period. Anti-dilutive shares represent potentially dilutive securities that are excluded from the computation of diluted income or loss per share as their impact would be anti-dilutive.
i
The following is a calculation of basic and diluted weighted-average shares outstanding:
Three
Months Ended September 30,
Nine Months Ended September 30,
(In thousands)
2021
2020
2021
2020
Weighted-average shares - basic
i399,664
i398,580
i399,459
i398,500
Dilution
effect of stock awards at end of period
i3,074
i—
i2,464
i2,128
Weighted-average
shares - diluted
i402,738
i398,580
i401,923
i400,628
/i
The
following table presents weighted-average shares excluded from diluted EPS due to the anti-dilutive effect:
Three Months Ended September 30,
Nine Months Ended September 30,
(In thousands)
2021
2020
2021
2020
Weighted-average
stock awards excluded from diluted EPS due to the anti-dilutive effect due to net loss
i—
i3,009
i—
i—
Weighted-average
stock awards excluded from diluted EPS due to the anti-dilutive effect calculated using the treasury stock method
ITEM 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
The following review of operations for the three and nine month periods ended September 30, 2021 and 2020 should be read in conjunction with our Condensed Consolidated Financial Statements and the Notes included in this Quarterly Report on Form 10-Q (this “Form 10-Q”) and with the Consolidated Financial Statements, Notes and Management’s Discussion and Analysis included in the Coterra Energy Inc. (formerly Cabot Oil & Gas Corporation) Annual Report on Form 10-K for the year ended December 31, 2020 (our “Form 10-K”).
OVERVIEW
Cimarex
Merger
On May 23, 2021, we entered into an Agreement and Plan of Merger (as amended as of June 29, 2021, the “Merger Agreement”) with Cimarex Energy Co. (“Cimarex”) to combine via a merger transaction pursuant to which our wholly owned subsidiary merged with and into Cimarex, with Cimarex surviving the merger as our subsidiary (“Merger”). The respective Boards of Directors of both companies unanimously approved the Merger in May 2021, proposals related to the Merger were approved by stockholders of both companies on September 29, 2021, and the Merger was completed on October 1, 2021. Cimarex is an oil and gas exploration
and production company with operations in Texas, New Mexico and Oklahoma.
Under the terms of the Merger Agreement, and subject to certain exceptions specified therein, each eligible share of Cimarex common stock was converted into the right to receive 4.0146 shares of our common stock at closing. As a result of the completion of the Merger, we issued approximately 408.2 million shares of common stock to Cimarex stockholders (excluding shares that were awarded in replacement of previously outstanding Cimarex restricted share awards). Based on the closing price of our common stock on October 1, 2021, the total value of such shares of Coterra common stock issued was approximately $9.1 billion.
Additionally on October 1, 2021, we changed our name to Coterra Energy Inc. and, after receiving
approval from our stockholders on September 29, 2021, increased the number of authorized shares of our common stock from 960,000,000 to 1,800,000,000.
Financial and Operating Overview
Financial and operating results for the nine months ended September 30, 2021 compared to the nine months ended September 30, 2020 reflect the following:
•Natural gas production decreased 15.3 Bcf from 639.2 Bcf, or 2,333 Mmcf per day, in the 2020 period to 623.9 Bcf, or 2,285 Mmcf per day, in the 2021 period. The decrease was driven by the timing of our drilling and completion activities in the Marcellus Shale in 2021.
•Average
realized natural gas price was $2.35 per Mcf, 47 percent higher than the $1.60 per Mcf realized in the corresponding period of the prior year.
•Total capital expenditures were $460.9 million compared to $463.9 million in the corresponding period of the prior year.
•Drilled 73 gross wells (70.1 net) with a success rate of 100 percent compared to 55 gross wells (49.2 net) with a success rate of 100 percent for the corresponding period of the prior year. Wells drilled represents wells drilled to total depth during the period.
•Completed 71 gross wells (67.1 net) in 2021 compared to 71 gross wells (62.3 net) in the corresponding period of 2020. Wells completed includes wells completed during the period, regardless of when they were drilled.
•Average
rig count during 2021 was approximately 2.7 rigs in the Marcellus Shale, compared to an average rig count of approximately 2.3 rigs during the corresponding period of 2020.
•Repaid $88.0 million of our 5.58% weighted-average senior notes, which matured in January 2021, and $100.0 million of our 3.65% weighted-average senior notes, which matured in September 2021.
Impact of the COVID-19 Pandemic
The ongoing coronavirus (“COVID-19”) outbreak, which the World Health Organization (WHO) declared as a pandemic in March 2020, has reached more than 200 countries and territories and there continues to be considerable uncertainty regarding the extent to which COVID-19 and its variants will continue to spread, the global availability and efficacy of treatments and
recently deployed vaccines and the extent and duration of governmental and other measures implemented to try to slow the spread of the virus and alleviate strain on the healthcare system and the economic impacts of those actions.
We have implemented preventative measures and developed response plans intended to minimize unnecessary risk of exposure and prevent infection among our employees and the communities in which we operate. Beginning in March 2020, we modified certain business practices (including those related to nonoperational employee work locations and the cancellation of physical participation in meetings, events and conferences) to conform to government restrictions and best practices encouraged by the Centers for Disease Control and Prevention, the WHO and
other governmental and regulatory authorities. In addition, we implemented and provided training on a COVID-19 Safety Policy containing personal safety protocols; provided additional personal protective equipment to our workforce; implemented rigorous COVID-19 self-assessment, contact tracing and quarantine protocols; increased cleaning protocols at all of our employee work locations; and provided additional paid leave to employees with actual or presumed COVID-19 cases. We also collaborated, and continue to collaborate, with customers, suppliers and service providers to minimize potential impacts to or disruptions of our operations and to implement longer-term emergency response protocols. Although we returned to full in-person working in our Houston headquarters and other offices in July 2021 (due to our determination that we could safely do so), we intend to continue to monitor developments affecting our workforce, our customers, our suppliers, our service providers
and the communities in which we operate, including any significant resurgence in COVID-19 transmission and infection. Should the need arise, we will take such precautions as we believe are warranted.
Our efforts to respond to the challenges presented by the ongoing pandemic, as well as certain operational decisions we previously implemented, such as our maintenance capital program, have helped to minimize the impact, and any resulting disruptions, of the pandemic to our business and operations. We have not required any loans under any COVID-19-related federal or other governmental programs to support our operations, and we do not expect to have to utilize any such funding.
The eventual impact that the COVID-19 pandemic will have on our business, cash flows, liquidity, financial condition and results of operations will depend on future developments, including, among others, the duration,
ultimate geographic spread and severity of the virus and its variants, any significant resurgence in virus transmission and infection in regions that have experienced improvements, the consequences of governmental and other measures designed to mitigate the spread of the virus and alleviate strain on the healthcare system, the distribution and effectiveness of therapeutic treatments and recently deployed vaccines and other actions by governmental authorities, customers, suppliers and other third parties.
Market Conditions and Commodity Prices
Our financial results depend on many factors, particularly commodity prices and our ability to market our production on economically attractive terms. Commodity prices are affected by many factors outside of our control, including changes in market supply and demand, which are impacted by pipeline capacity constraints, inventory storage levels,
basis differentials, weather conditions and other factors. Our realized prices are also further impacted by our hedging activities.
Our revenues, operating results, financial condition and ability to borrow funds or obtain additional capital depend substantially on prevailing commodity prices, particularly natural gas prices. Since material declines in commodity prices could have a material adverse effect on our operating results, financial condition, liquidity and ability to obtain financing. Lower commodity prices also may reduce the amount of oil, natural gas, and natural gas liquids (“NGL”) that we can produce economically. In addition, in periods of low commodity prices, we may elect to curtail a portion of our production from time to time. Historically, commodity prices have been volatile, with prices sometimes fluctuating widely, and they may remain volatile. As a result, we cannot accurately predict future commodity
prices and, therefore, cannot determine with any degree of certainty what effect increases or decreases in these prices will have on our capital program, production volumes or revenues. In addition to commodity prices and production volumes, finding and developing sufficient amounts of oil and natural gas reserves at economical costs are critical to our long-term success.
We account for our derivative instruments on a mark-to-market basis, with changes in fair value recognized in operating revenues in the Condensed Consolidated Statement of Operations. As a result of these mark-to-market adjustments associated with our derivative instruments, we will experience volatility in our earnings due to commodity price volatility. Refer to “Results of Operations — Impact of Derivative Instruments on Operating Revenues” below and Note 5 of the Notes to the Condensed Consolidated Financial Statements for more information.
One
of the impacts of the COVID-19 pandemic was a significant reduction in demand for crude oil, and to a lesser extent, natural gas. The supply/demand imbalance driven by the COVID-19 pandemic and production disagreements in March 2020 among members of the Organization of Petroleum Exporting Countries and certain other oil exporting countries (OPEC+) led to a significant global economic contraction generally in 2020 and continued to have disruptive impacts on the oil and gas industry in 2021. Although the members of OPEC+ agreed in April 2020 to cut oil production and have subsequently taken actions that generally have supported commodity prices, and U.S. production has declined, oil prices and natural gas prices remained low,
relative to pre-pandemic levels, through the first quarter of 2021, as the oversupply and lack of demand in the market persisted. Oil, natural gas and NGL prices increased in the third quarter of 2021 compared to the third quarter of 2020 and have further strengthened after the end of the third quarter of 2021, in part due to greater demand during the early summer heating season and slightly decreasing production levels.
Meanwhile, NYMEX oil and natural gas futures prices have strengthened since the reduction of pandemic-related restrictions and recent OPEC+ cooperation. Improving oil and natural gas futures prices in part reflect market expectations of limited US supply growth from publicly traded companies as a result of capital investment discipline and a focus on
delivering free cash flow returns to stockholders. In addition, natural gas prices have benefited from strong worldwide liquefied natural gas (“LNG”) demand and sustained higher U.S. exports, lower associated gas growth from oil drilling and improved U.S. economic activity. Oil price futures have improved coinciding with recovering global economic activity, lower supply from major oil producing countries, OPEC+ cooperation and moderating inventory levels.
Although the current outlook on oil and natural gas prices is generally favorable and our operations have not been significantly impacted in the short-term, in the event further disruptions occur and continue for an extended period of time, our operations could be adversely impacted, commodity prices could decline and our costs may increase. Although we are unable to predict future commodity prices, at current oil, natural gas and NGL price levels, we do not believe
that an impairment of our oil and gas properties is reasonably likely to occur in the near future; however, in the event that commodity prices significantly decline from current levels, our management would evaluate the recoverability of the carrying value of our oil and gas properties.
We currently believe that we are well-positioned to manage the challenges presented by the volatility in the commodity pricing environment, and we believe we can endure continued volatility in current and future commodity prices by continuing to:
•Exercise discipline in our capital program with the expectation of funding our capital expenditures with cash on hand, operating cash flows, and if required, borrowings under our revolving credit facility;
•Manage our portfolio by strategically curtailing production
in periods of weaker commodity prices;
•Optimize our drilling, completion and operational efficiencies;
•Manage our balance sheet, which (when taken together with availability under our revolving credit facility) provides sufficient cash availability to meet our capital requirements and maintain compliance with our debt covenants; and
•Manage price risk by strategically hedging our production.
For information about the impact of realized commodity prices on our revenues, refer to “Results of Operations” below.
Outlook
We expect our fourth quarter 2021 capital program to be approximately $245.0 million to $275.0 million for the combined
company after the Merger with Cimarex. We expect to fund these capital expenditures with our operating cash flow and, if required, cash on hand.
In 2020, we drilled 74 gross wells (64.3 net) and completed 86 gross wells (77.3 net), of which 26 gross wells (26.0 net) were drilled but uncompleted in prior years. For the first nine months of 2021, our capital program focused on the Marcellus Shale, where we drilled 70.1 net wells and completed 67.1 net wells. Our fourth quarter 2021 capital program will focus on the Permian Basin, where we are currently running five rigs and two completion crews, and the Marcellus Shale, where we are currently running two rigs and two completion crews. We allocate our planned program for capital expenditures based on market conditions, return on capital and free cash flow expectations and availability of services and human resources. We will continue to assess the natural gas price environment
and may adjust our capital expenditures accordingly.
Financial Condition
Capital Resources and Liquidity
Our primary source of cash for the nine months ended September 30, 2021 was from net cash flows related to the sale of natural gas production. These cash flows were used to fund our capital expenditures, principal and interest payments on debt and payment of dividends. See below for additional discussion and analysis of our cash flows.
The borrowing base under the terms of our revolving credit facility was redetermined annually in April until the most recent amendment to the credit agreement in September 2021. Effective April 21, 2021, the borrowing base and available commitments were reaffirmed at $3.2 billion and $1.5 billion, respectively.
On June 17, 2021, we entered into an amendment to the credit agreement relating to our revolving credit facility to, among other things, (1) remove the requirement that certain of our restricted subsidiaries become guarantors under the credit agreement, (2) expand the permissible
indebtedness that may be held or incurred by a restricted subsidiary and (3) make certain other changes to permit us to complete the Merger. This amendment became effective upon completion of the Merger on October 1, 2021.
On September 16, 2021, we entered into another amendment to the credit agreement to, among other things: (1) remove the provisions which limited borrowings thereunder to an amount not to exceed the borrowing base and certain related provisions; (2) replace the then-existing financial maintenance covenants with a covenant requiring maintenance of a ratio of total debt to consolidated EBITDA of not more than 3.0 to 1.0; (3) provide that if, in the future, we no longer have any other indebtedness subject to a leverage-based financial maintenance covenant, then the leverage covenant shall be replaced by a covenant
requiring maintenance of a ratio of total debt to total capitalization not to exceed 65 percent at any time; and (4) provide for changes to certain exceptions to the negative covenants to reflect the completion of the Merger. This amendment became effective upon completion of the Merger on October 1, 2021, and closing of the debt exchange described below.
At September 30, 2021, we had no borrowings outstanding under our revolving credit facility and our unused commitments were $1.5 billion. Refer to Note 4 of the Notes to the Condensed Consolidated Financial Statements for more information.
We strive to manage our debt at a level below the available credit line in order to maintain borrowing capacity. Our revolving credit facility includes a covenant limiting our borrowing capacity
based on our leverage ratio. We believe that, with operating cash flows, cash on hand and availability under our revolving credit facility, we have the capacity to fund our spending plans.
At September 30, 2021, we were in compliance with all financial and other covenants applicable to our revolving credit facility and senior notes. Refer to our Form 10-K for further discussion of our restrictive financial covenants.
On October 7, 2021 and after the completion of the Merger, we completed the exchange of $1.8 billion in aggregate principal of Cimarex senior notes (“Existing Cimarex Notes”) for $1.8 billion in aggregate principal of new notes issued by us (“New Coterra Notes”) and $1.8 million of cash consideration. In connection with the debt exchange, Cimarex obtained
consents to adopt certain amendments to each of the indentures governing the Existing Cimarex Notes to eliminate certain of the covenants, restrictive provisions and events of default from such indentures. The New Coterra Notes are general, unsecured, senior obligations of ours and have substantially identical terms and covenants to the Existing Cimarex Notes (before giving effect to the amendments referred to in the immediately preceding sentence), which we believe are customary for senior, unsecured notes issued by companies of similar size and credit quality as compared to us. The New Coterra Notes consist of $705.5 million aggregate principal amount of 4.375% Senior Notes due 2024, $687.2 million aggregate principal amount of 3.90% Senior Notes due 2027 and $433.2 million aggregate principal
amount of 4.375% Senior Notes due 2029.
Cash Flows
Our cash flows from operating activities, investing activities and financing activities were as follows:
Nine Months Ended September 30,
(In thousands)
2021
2020
Cash
flows provided by operating activities
$
714,663
$
470,393
Cash flows used in investing activities
(458,721)
(487,546)
Cash flows used in financing activities
(321,382)
(184,882)
Net
decrease in cash, cash equivalents and restricted cash
$
(65,440)
$
(202,035)
Operating Activities. Fluctuations in our operating cash flows are substantially driven by commodity prices, changes in our production volumes and operating expenses. Commodity prices have historically been volatile, primarily as a result of supply and demand for natural gas, pipeline infrastructure constraints, basis differentials, inventory storage levels, seasonal influences and other factors. In addition, fluctuations in cash flows may result in an increase or decrease in our capital expenditures.
Our working capital is substantially influenced by the variables discussed above and fluctuates based on the timing and amount of borrowings and repayments under our revolving credit facility, repayments of debt, the timing of cash collections and payments on our trade accounts receivable and payable, respectively, payment of dividends, repurchases of our securities and changes in the fair value of our commodity derivative activity. From time to time, our working capital will reflect a deficit, while at other times it will reflect a surplus. This fluctuation is not unusual. At September 30, 2021 and December 31, 2020, we had a working capital deficit of $23.3 million and a surplus of $25.5 million, respectively.
We believe that we have adequate liquidity and availability under our revolving credit facility to meet our working capital requirements over the next 12 months.
Net cash provided by operating activities in the first nine months of 2021 increased by $244.3 million compared to the first nine months of 2020. This increase was primarily due to higher natural gas revenues, partially offset by lower cash received from derivative settlements, higher operating expenses and higher net cash outflows related to certain other current asset and liability balances reflected in working capital compared to the corresponding period of the prior year. The increase in natural gas revenues was primarily due to higher realized prices, partially offset by lower production. Average realized natural gas prices increased by 47 percent for the first nine months of 2021 compared to the first nine months of 2020. The decrease in natural gas production
for the first nine months of 2021 compared to the first nine months of 2020 was driven by the timing of our drilling and completion activities in the Marcellus Shale in 2021.
Refer to “Results of Operations” below for additional information relative to commodity price, production and operating expense fluctuations. We are unable to predict future commodity prices and, as a result, cannot provide any assurance about future levels of net cash provided by operating activities.
Investing Activities. Cash flows used in investing activities decreased by $28.8 million for the first nine months of 2021 compared to the first nine months of 2020. The decrease was primarily due to $19.4 million of lower capital expenditures as a result of the continuation of our maintenance capital program in 2021 and a decrease in net cash outflows of
$9.4 million related to the sale of equity method investments in 2020.
Financing Activities. Cash flows used in financing activities increased by $136.5 million for the first nine months of 2021 compared to the first nine months of 2020. This increase was primarily due to $129.0 million higher net repayments of debt in 2021 compared to 2020 and $8.3 million higher dividends paid as a result of an increase in our dividend rate from $0.10 per share to $0.11 per share in April 2021.
Capitalization
Information about our capitalization is as follows:
We did not repurchase any shares of our common stock during the first nine months of 2021 and 2020. During the first nine months of 2021 and 2020, we paid dividends of $127.8 million ($0.32 per share) and $119.5 million ($0.30 per share), respectively, on our common stock.
In April 2021, our Board of Directors approved an increase in the quarterly dividend on our common stock from $0.10 per share to $0.11 per share.
On October 1, 2021 and upon closing the Merger, we issued approximately 408.2 million shares of common stock to Cimarex stockholders under the terms of the Merger
Agreement (excluding restricted share that were awarded in replacement of previously outstanding Cimarex restricted share awards).
On September 29, 2021, our stockholders approved an amendment to our certificate of incorporation to increase the number of authorized shares of our common stock from 960,000,000 shares to 1,800,000,000 shares. That amendment became effective on October 1, 2021.
On
October 4, 2021, and in connection with the closing of the Merger, our Board of Directors approved a special dividend of $0.50 per share payable on our common stock on October 22, 2021. On November 3, 2021, our Board of Directors approved an increase in the quarterly dividend on our common stock from $0.11 per share to $0.125 per share. Also on that date, related to our dividend strategy to return at least 50 percent of quarterly free cash flows to stockholders, the Board of Directors approved a variable dividend of $0.175 per share, for a total dividend of $0.30 per share, payable on our common stock on November 24, 2021 .
Capital and Exploration Expenditures
On an annual basis, we generally
fund most of our capital expenditures, excluding any significant property acquisitions, with operating cash flows, cash on hand and, if required, borrowings under our revolving credit facility. We budget these expenditures based on our projected cash flows for the year.
The following table presents major components of our capital and exploration expenditures:
(1)There were no exploratory dry hole costs for the first nine months of 2021. Exploration expenditures include $2.0 million of exploratory dry hole costs for the first nine months of 2020.
For
the first nine months of 2021, our capital program was focused on the Marcellus Shale, where we drilled 70.1 net wells and completed 67.1 net wells. We expect our fourth quarter 2021 capital program to be approximately $245.0 million to $275.0 million for the combined company after the Merger with Cimarex. Our fourth quarter capital program will focus on the Permian Basin, where we are currently running five rigs and two completion crews, and the Marcellus Shale, where we are currently running two rigs and two completion crews. Refer to “Outlook” for additional information regarding the current year drilling program. We will continue to assess the commodity price environment and may increase or decrease our capital expenditures accordingly.
Contractual Obligations
We have various contractual obligations in the normal course of our operations. Other than as a result of the
Merger, there have been no material changes to our contractual obligations described under “Transportation and Gathering Agreements” and “Lease Commitments” as disclosed in Note 9 of the Notes to the Consolidated Financial Statements and the obligations described under “Contractual Obligations” in Item 7 “Management’s Discussion and Analysis of Financial Condition and Results of Operations” included in our Form 10-K.
Critical Accounting Policies and Estimates
Our discussion and analysis of our financial condition and results of operations are based on our Condensed Consolidated Financial Statements, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these financial
statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses. Refer to our Form 10-K for further discussion of our critical accounting policies.
Results of Operations
Third Quarters of 2021 and 2020 Compared
We reported net income in the third quarter of 2021 of $62.7 million, or $0.16 per share, compared to a net loss of $15.0 million, or $0.04 per share, in the third quarter of 2020. The increase in net income was primarily due to higher operating revenues and lower interest expense, partially offset by higher operating expenses and income tax expense.
Our revenues vary from year to year as a result of changes in commodity prices and production volumes. Below is a summary of revenues, price and volume variances.
Three
Months Ended September 30,
Variance
(In thousands)
2021
2020
Amount
Percent
Operating Revenues
Natural gas
$
641,625
$
333,256
$
308,369
93
%
(Loss)
gain on derivative instruments
(201,282)
(42,253)
(159,029)
(376)
%
Other
53
38
15
39
%
$
440,396
$
291,041
$
149,355
51
%
Natural
Gas Revenue Price and Volume Variances
Three Months Ended September 30,
Variance
Increase (Decrease) (In thousands)
2021
2020
Amount
Percent
Average
price ($/Mcf)
$
2.95
$
1.51
$
1.44
95
%
$
314,409
Volume (Bcf)
217.4
221.4
(4.0)
(2)
%
(6,040)
Total
$
308,369
The
increase in natural gas revenues of $308.4 million was primarily due to higher natural gas prices, partially offset by a decrease in production. Production decreased due to the timing of our drilling and completion activities in the Marcellus Shale in 2021.
Impact of Derivative Instruments on Operating Revenues
Three Months Ended September 30,
(In thousands)
2021
2020
Cash
received (paid) on settlement of derivative instruments
Total
costs and expenses from operations increased by $46.1 million in the third quarter of 2021 compared to the corresponding period of 2020. The primary reasons for this fluctuation are as follows:
•Direct operations increased $1.2 million. No changes in direct operations expenses were individually significant.
•Transportation and gathering increased $1.8 million, primarily due to $2.1 million higher gathering charges as a result of an increase in the gathering rate, partially offset by lower production.
•Taxes other than income increased $4.6 million, primarily due to $4.2 million higher drilling impact fees driven by an increase in rates associated with higher natural gas prices.
•Depreciation, depletion
and amortization (“DD&A”) decreased $2.4 million, primarily due to lower amortization of unproved properties of $1.9 million and lower DD&A of $0.6 million in the third quarter of 2021 compared to the third quarter of 2020. Amortization of unproved properties decreased due to lower amortization rates. The decrease in DD&A was primarily due to lower equivalent production. The DD&A rate was flat at $0.43 per Mcfe for the third quarter of 2021 and 2020.
•General and administrative increased $40.8 million, primarily due to $40.1 million of transaction-related costs associated with the Merger, partially offset by lower stock-based compensation expense of $1.1 million associated with certain of our market-based performance awards. The remaining changes in general and administrative expenses were not individually significant.
Interest Expense,
net
Interest expense, net decreased $1.8 million, primarily due to the repayment of $87.0 million of our 6.51% weighted-average senior notes, which matured in July 2020, the repayment of $88.0 million of our 5.58% weighted-average senior notes, which matured in January 2021, and the repayment of $100.0 million of our 3.65% weighted-average senior notes, which matured in September 2021.
Income Tax Expense (Benefit)
Income tax expense increased $27.5 million due to higher pre-tax income in the third quarter of 2021 compared to a pre-tax loss in the third quarter of 2020, partially offset by a lower effective tax rate. The effective tax rates for the third quarter of 2021 and 2020 were 24.6 percent and 31.9 percent, respectively. The effective tax rate was lower for the third quarter of 2021 compared to the third quarter of 2020 due to differences
in the non-recurring discrete items recorded during the third quarter of 2021 versus the third quarter of 2020. Income tax expense was higher in the third quarter of 2021 due to non-deductible transaction costs related to the Merger, and income tax expense was lower in the third quarter of 2020 due to tax benefits related to an amended tax return filing.
We reported net income in the first nine months of 2021 of $219.5 million, or $0.55 per share, compared to net income of $69.3
million, or $0.17 per share, in the first nine months of 2020. The increase in net income was primarily due to higher operating revenues and lower interest expense, partially offset by higher operating expenses and income tax expense.
Revenues
Our revenues vary from year to year as a result of changes in commodity prices and production volumes. Below is a summary of revenues, price and volume variances.
Nine
Months Ended September 30,
Variance
(In thousands)
2021
2020
Amount
Percent
Operating Revenues
Natural gas
$
1,526,202
$
991,882
$
534,320
54
%
(Loss)
gain on derivative instruments
(301,641)
17,783
(319,424)
(1,796)
%
Other
182
181
1
1
%
$
1,224,743
$
1,009,846
$
214,897
21
%
Natural
Gas Revenue Price and Volume Variances
Nine Months Ended September 30,
Variance
Increase (Decrease) (In thousands)
2021
2020
Amount
Percent
Average
price ($/Mcf)
$
2.45
$
1.55
$
0.90
58
%
$
558,098
Volume
(Bcf)
623.9
639.2
(15.3)
(2)
%
(23,778)
Total
$
534,320
The
increase in natural gas revenues of $534.3 million was primarily due to higher natural gas prices, partially offset by lower production. The decrease in production was due to the timing of our drilling and completion activities in the Marcellus Shale in 2021.
Impact of Derivative Instruments on Operating Revenues
Nine Months Ended September 30,
(In thousands)
2021
2020
Cash
received (paid) on settlement of derivative instruments
Total costs and expenses from operations increased by $22.8 million in the first nine months of 2021 compared to the corresponding period of 2020. The primary reasons for this fluctuation are as follows:
•Direct operations decreased $0.5 million, primarily due to a decrease in production.
•Transportation and
gathering decreased $6.6 million, primarily due to lower gathering charges as a result of lower production, partially offset by a higher gathering rate.
•Taxes other than income increased $6.5 million, primarily due to $6.2 million higher drilling impact fees driven by an increase in rates associated with higher natural gas prices.
•Exploration expense decreased $1.7 million, primarily due to $2.0 million of dry hole expense recognized in 2020.
•Depreciation, depletion and amortization decreased $11.4 million, primarily due to lower DD&A of $5.6 million and lower amortization of unproved properties of $6.3 million. The decrease in DD&A was due to lower production in 2021 compared to the corresponding period of 2020. The DD&A rate was flat at $0.44 per Mcfe
for the first nine months of 2021 and 2020. Amortization of unproved properties decreased due to lower amortization rates.
•General and administrative increased $36.4 million, primarily due to $46.3 million of transaction-related costs associated with the Merger and $2.4 million of higher severance costs incurred in the first quarter of 2021 related to our early retirement program, partially offset by lower stock-based compensation expense of $9.7 million associated with certain of our market-based performance awards and a $2.8 million decrease in previously accrued fines and penalties related to compliance matters with the Office of Natural Resource Revenue. The remaining changes in general and administrative expenses were not individually significant.
Interest Expense, net
Interest expense, net decreased $5.6 million,
primarily due to the repayment of $87.0 million of our 6.51% weighted-average senior notes, which matured in July 2020, the repayment of $88.0 million of our 5.58% weighted-average senior notes, which matured in January 2021, and the repayment of $100.0 million of our 3.65% weighted-average senior notes, which matured in September 2021.
Income Tax Expense
Income tax expense increased $48.1 million due to higher pre-tax income and a higher effective tax rate. The effective tax rates for the first nine months of 2021 and 2020 were 23.7 percent and 22.3 percent, respectively. The effective tax rate was higher for the first nine months of 2021 compared to the first nine months of 2020 primarily due to differences in the non-recurring discrete items recorded during the first nine months of 2021 compared to the first nine months of 2020.
The statements regarding future financial and operating performance and results, strategic pursuits and goals, market prices, future hedging and risk management activities, the anticipated benefits of the Merger, the anticipated impact of the Merger on our business and other statements that are not historical facts contained in this report are forward-looking statements. The words ‘expect”, “project”, “estimate”, “believe”, “anticipate”, “intend”, ‘budget’, ‘plan”, “forecast”, “target”, “predict”, “may”, “should”, ‘could” and similar expressions are also intended to identify forward-looking statements. Such statements involve risks and uncertainties, including, but not limited
to, the continuing effects of the COVID-19 pandemic and the impact thereof on our business, financial condition and results of operations, the availability of cash on hand and other sources of liquidity to fund our capital expenditures, actions by, or disputes among or between, members of OPEC+, market factors, market prices (including geographic basis differentials) of oil and natural gas, results of future drilling and marketing activity, future production and costs, the risk that the Company’s and Cimarex’s businesses will not be integrated successfully, the risk that the cost savings and any other synergies from the Merger may not be fully realized or may take longer to realize than expected, legislative and regulatory initiatives, electronic, cyber or physical security breaches and other factors detailed herein and in our other Securities and Exchange Commission (“SEC”) filings.
Refer to “Risk Factors” in Item 1A of Part I of our Form 10-K and in Item 1A of Part II of this Form 10-Q for additional information about these risks and uncertainties. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual outcomes may vary materially from those indicated.
ITEM 3. Quantitative and Qualitative Disclosures about Market Risk
Market Risk
Prior to the Merger, our primary market risk was exposure to natural gas prices. Realized prices are mainly driven by spot market prices for North American natural gas production, which can be volatile and unpredictable.
Derivative Instruments and Risk Management
Activities
Our risk management strategy is designed to reduce the risk of commodity price volatility for our production in the natural gas markets through the use of financial commodity derivatives. A committee that consists of members of senior management oversees our risk management activities. Our financial commodity derivatives generally cover a portion of our production and provide only partial price protection by limiting the benefit to us of increases in prices, while protecting us in the event of price declines. Further, if any of our counterparties defaulted, this protection might be limited as we might not receive the full benefit of our financial commodity derivatives. Please read the discussion below as well as Note 6 of the Notes to the Consolidated Financial Statements in our Form 10-K for a more detailed discussion of our derivative instruments.
Periodically, we enter
into financial commodity derivatives including collar and swap agreements, to protect against exposure to commodity price declines related to our natural gas production. Our credit agreement restricts our ability to enter into financial commodity derivatives other than to hedge or mitigate risks to which we have actual or projected exposure or as permitted under our risk management policies and not subjecting us to material speculative risks. All of our financial derivatives are used for risk management purposes and are not held for trading purposes. Under the collar agreements, if the index price rises above the ceiling price, we pay the counterparty. If the index price falls below the floor price, the counterparty pays us. Under the swap agreements, we receive a fixed price on a notional quantity of natural gas in exchange for paying a variable price based on a market-based index, such as the NYMEX natural gas futures.
The
amounts set forth in the table above represent our total unrealized derivative position at September 30, 2021 and exclude the impact of non-performance risk. Non-performance risk is considered in the fair value of our derivative instruments that are recorded in our Condensed Consolidated Financial Statements and is primarily evaluated by reviewing credit default swap spreads for the various financial institutions with which we have derivative contracts, while our non-performance risk is evaluated using a market credit spread provided by several of our banks.
Subsequent event. As a result of the Merger, we acquired the following outstanding financial commodity derivatives:
(1)The index price we pay under these basis swaps is WTI Midland as quoted by Argus Americas Crude.
A
significant portion of our expected natural gas production for 2021 and beyond is currently unhedged and directly exposed to the volatility in natural gas prices, whether favorable or unfavorable.
During the first nine months of 2021, natural gas collars with floor prices ranging from $2.50 to $2.85 per Mmbtu and ceiling prices ranging from $2.80 to $3.94 per Mmbtu covered 128.2 Bcf, or 21 percent of natural gas production at a weighted-average price of $2.87 per Mmbtu. Natural gas swaps covered 31.0 Bcf, or five percent of our natural gas production at a weighted-average price of $2.76 per Mmbtu.
We are exposed to market risk on financial commodity derivative instruments to the extent of changes in market prices of natural gas. However, the market risk exposure on these derivative contracts
is generally offset by the gain or loss recognized upon the ultimate sale of the commodity. Although notional contract amounts are used to express the volume of natural gas agreements, the amounts that can be subject to credit risk in the event of non-performance by third parties are substantially smaller. Our counterparties are primarily commercial banks and financial service institutions that our management believes present minimal credit risk and our derivative contracts are with multiple counterparties to minimize our exposure to any individual counterparty. We perform both quantitative and qualitative assessments of these counterparties based on their credit ratings and credit default swap rates where applicable. We have not incurred any losses related to non-performance risk of our
counterparties and we do not anticipate any material impact on our financial results due to non-performance by third parties. However, we cannot be certain that we will not experience such losses in the future.
The preceding paragraphs contain forward-looking information concerning future production and projected gains and losses, which may be impacted by both production and changes in the future commodity prices. Refer to “Forward-Looking Information” for further details.
Fair Value of Other Financial Instruments
The estimated fair value of other financial instruments is the amount at which the instrument could be exchanged currently between willing parties. The carrying amounts reported in the Condensed Consolidated Balance Sheet for cash, cash equivalents and restricted cash approximate fair value due to the short-term maturities
of these instruments.
We use available market data and valuation methodologies to estimate the fair value of debt. The fair value of debt is the estimated amount we would have to pay a third party to assume the debt, including a credit spread for the difference between the issue rate and the period end market rate. The credit spread is our default or repayment risk. The credit spread (premium or discount) is determined by comparing our outstanding debt to new issuances (secured and unsecured) and secondary trades of similar size and credit statistics for both public and private debt. The estimated fair value of our outstanding debt is based on interest rates currently available to us.
As of September 30, 2021, we carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures pursuant to Rules 13a-15 and 15d-15 of the Securities Exchange Act of 1934 (the Exchange Act). Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures are effective, in all material respects, with respect to the recording, processing, summarizing and reporting, within the time periods specified in the Commission’s rules and forms, of information required to be disclosed by us in the reports that we file or submit under the Exchange Act.
There were
no changes in our internal control over financial reporting that occurred during the third quarter of 2021 that have materially affected, or are reasonably likely to have a material effect on, our internal control over financial reporting.
The information set forth under the heading “Legal Matters” in Note 8 of the Notes to Condensed Consolidated Financial Statements included in Item 1 of Part I of this Form 10-Q is incorporated by reference in response to this item.
Environmental Matters
From time to time, we receive notices of violation from governmental and regulatory authorities in areas in which we operate relating to alleged violations of environmental statutes or the rules and regulations promulgated thereunder. Although we cannot predict with certainty whether these notices of violation will result in fines and/or penalties, if fines and/or penalties are imposed, they may result in monetary sanctions, individually or in the aggregate, in excess of $300,000.
ITEM
1A. Risk Factors
The following is a discussion of risk factors relating to the Merger. For additional information about risk factors that affect us, refer to Item 1A of Part I of ours and Cimarex’s Form 10-K for the year ended December 31, 2020 and subsequent Forms 10-Q of Coterra and Cimarex.
The failure to integrate our businesses and operations with those of Cimarex successfully in the expected time frame may adversely affect the combined business’ future results.
The Merger involved the combination of two companies that previously operated as independent public companies. It is possible that the process of integrating the two businesses following the Merger could result in the loss of key employees, the disruption of either or both companies’ ongoing businesses, inconsistencies in standards,
controls, procedures and policies, potential unknown liabilities, unforeseen expenses or delays or higher-than-expected integration costs and an overall post-completion integration process that takes longer than originally anticipated.
The Merger may result in a loss of customers, distributors, service providers, suppliers, vendors, joint venture participants and other business counterparties and may result in the termination of existing contracts.
As a result of the Merger, some of our and Cimarex’s legacy customers, distributors, service providers, suppliers, vendors, joint venture participants and other business counterparties may terminate or scale back their current or prospective business relationships with the combined business. If relationships with customers, distributors, service
providers, suppliers, vendors, joint venture participants and other business counterparties are adversely affected by the Merger, our business, financial condition, results of operations and cash flows could be materially and adversely affected.
The combined business may fail to realize all of the anticipated benefits of the Merger.
The success of the Merger will depend, in part, on our ability to realize the anticipated benefits and cost savings from combining our two businesses and operational synergies. The anticipated benefits and cost savings of the Merger may not be realized fully or at all, may take longer to realize than expected, may not be realized or could have other adverse effects that we do not currently foresee. Some of the assumptions that we have made, such as the achievement of the anticipated benefits related to the geographic, commodity and asset diversification
and the expected size, scale, inventory and financial strength of the combined business, may not be realized. In addition, there could be potential unknown liabilities and unforeseen expenses associated with the Merger that could adversely impact the combined business.
The market price of our common stock may fluctuate for various reasons and may decline if large amounts of our common stock are sold following the Merger.
The market price of our common stock may fluctuate significantly in the future and holders of our common stock could lose some or all of the value of their investment. As a result of the Merger, we issued approximately 408.2 million shares of our common stock to former Cimarex stockholders (excluding restricted shares that were awarded in replacement of previously outstanding Cimarex restricted share awards). The Merger Agreement contained no restrictions on the ability
of former Cimarex stockholders or our historic stockholders to sell or otherwise dispose of shares of our common stock. Former Cimarex stockholders may decide not to hold the shares of our common stock that they received in the Merger, and our historic stockholders may decide to reduce their investment in us as a result of the changes to our investment profile as a result of the Merger. These sales of our common stock (or the perception that these sales may occur) could have the effect of depressing the market price for our common stock. In addition, with the completion of the Merger, our financial position is different from our
financial
position before the completion of the Merger, and our future results of operations and cash flows will be affected by factors different from those that previously affected our results of operations and cash flows, all of which could adversely affect the market price of our common stock. Furthermore, the stock market has experienced significant price and volume fluctuations in recent times which, if they continue to occur, could have a material adverse effect on the market for, or liquidity of, our common stock, regardless of our actual operating performance.
The increase in our indebtedness as a result of the Merger may limit our financial flexibility.
Following the Merger, our legacy revolving credit facility and senior notes remained outstanding. In addition, on October 7, 2021, we completed an exchange offer, whereby we issued $1.8
billion in aggregate principal amount of new senior notes in exchange for $1.8 billion in aggregate principal amount of previously outstanding Cimarex senior notes. Following completion of that exchange offer, $0.2 billion in aggregate principal amount of Cimarex senior notes remained outstanding. The increase in our indebtedness as a result of the Merger and related transactions could have adverse effects on our business, financial condition, results of operations and cash flows, including by:
•imposing additional cash requirements in order to support interest payments, which could limit the amount available to fund our operations and other business activities;
•increasing the risk of default on debt obligations;
•increasing our vulnerability to adverse changes in general
economic and industry conditions, economic downturns and adverse developments in its business;
•limiting our ability to sell assets, engage in strategic transactions or obtain additional financing for working capital, capital expenditures, general corporate and other purposes;
•limiting our flexibility in planning for or reacting to changes in our business and the industry in which we operate; and
•increasing our exposure to a rise in interest rates, which would generate greater interest expense to the extent we do not have applicable interest rate fluctuation hedges.
We have incorporated Cimarex’s hedging activities into our business, and we may be exposed to additional commodity price risks arising from such hedges.
To
mitigate a portion of its exposure to changes in commodity prices, Cimarex has historically hedged oil and natural gas prices from time to time, primarily through the use of certain derivative instruments. Upon completion of the Merger, we assumed Cimarex’s existing hedges, such that we will now bear the economic impact of those hedges. Actual crude oil and natural gas prices may differ from expectations and, as a result, such hedges could have a negative impact on our financial condition, results of operations and cash flows.
The declaration, payment and amounts of future dividends distributed to our stockholders will be uncertain.
Although we and Cimarex have paid cash dividends on shares of common stock in the past, our Board of Directors may determine not to declare dividends in the future or may reduce the amount of dividends paid in the future. Decisions on whether, when and
in which amounts to declare and pay any future dividends will remain in the discretion of our Board of Directors. Any dividend payment amounts will be determined by our Board of Directors on a quarterly basis, and it is possible that our Board of Directors may increase or decrease the amount of dividends paid in the future, or determine not to declare dividends in the future, at any time and for any reason. We expect that any such decisions will depend on our financial condition, results of operations, cash balances, cash requirements, future prospects, the outlook for commodity prices and other considerations that our Board of Directors deems relevant, including, but not limited to:
•whether we have enough cash to pay such dividends due to our cash requirements, capital spending plans, cash flows or financial position;
•our desire to
maintain or improve the credit ratings on our debt; and
•applicable restrictions under Delaware law.
Common stockholders should be aware that they have no contractual or other legal right to dividends that have not been declared.
As a result of the Merger, we may record goodwill and other intangible assets that could become impaired and result in material non-cash charges to our results of operations in the future.
In
accordance with Accounting Standards Codification Topic 805, Business Combinations, the Merger will be accounted for as an acquisition by Coterra pursuant to the acquisition method of accounting for business combinations. Under the acquisition method of accounting, we will record the net tangible and identifiable intangible assets and liabilities of Cimarex and its subsidiaries as of the consummation of the Merger, at their respective fair values. Our reported financial condition and results of operations for periods after consummation of the Merger will reflect Cimarex balances and results after consummation of the Merger but will not be restated retroactively to reflect the historical financial position or results of operations of Cimarex and its subsidiaries
for periods prior to the Merger.
Under the acquisition method of accounting, the total purchase price will be allocated to Cimarex’s tangible assets and liabilities and identifiable intangible assets based on their fair values as of the date of completion of the Merger, with any excess purchase price allocated to goodwill. To the extent the value of goodwill or intangibles, if any, becomes impaired in the future, the combined business may be required to recognize material non-cash charges relating to such impairment. The combined business’ operating results may be significantly impacted from both the impairment and the underlying trends in the business that triggered the impairment.
Our ability to utilize Cimarex’s historic net operating loss carryforwards may be limited.
As of December 31,
2020, Cimarex had U.S. federal net operating loss carryforwards (“NOLs”) of approximately $2.0 billion, $1.8 billion of which is subject to expiration in years 2032 through 2037 and $224.4 million of which is not subject to expiration. Our ability to utilize these NOLs and other tax attributes to reduce future taxable income depends on many factors, including future income, which cannot be assured. Section 382 of the Internal Revenue Code of 1986, as amended (“Section 382”) generally imposes an annual limitation on the amount of NOLs that may be used to offset taxable income when a corporation has undergone an “ownership change” (as determined under Section 382). An ownership change generally occurs if one or more stockholders (or groups of stockholders) who are each deemed to own at least 5 percent of such corporation’s stock increase their ownership by more than 50 percentage points over their lowest ownership percentage within a rolling three-year
period.
As a result of the Merger, we believe that an ownership change occurred with respect to Cimarex under Section 382, which triggered a limitation (calculated as described below) on Coterra’s ability to utilize Cimarex’s historic NOLs and could cause some of those NOLs to expire unutilized. This annual limitation under Section 382, is determined by multiplying (1) the fair market value of Cimarex’s stock at the time of the Merger by (2) the long-term tax exempt rate published by the Internal Revenue Service for the month in which the Merger occurred, subject to certain adjustments (provided that any unused annual limitation may be carried over to later years).In addition, the NOLs Cimarex acquired in 2019 as part of its acquisition of Resolute Energy Corporation are already subject to a Section 382 limitation.
ITEM
2. Unregistered Sales of Equity Securities and Use of Proceeds
Issuer Purchases of Equity Securities
Our Board of Directors has authorized a share repurchase program under which we may purchase shares of common stock in the open market or in negotiated transactions. There is no expiration date associated with the authorization. There were no repurchases during the quarter ended September 30, 2021. The maximum number of remaining shares that may be purchased under our share repurchase program as of September 30, 2021 was 11.0 million shares.
Inline XBRL Instance Document. The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
†Schedules have been omitted pursuant to Item 601(b)(2) of Regulation S-K. Coterra hereby undertakes to furnish supplementally copies of any of the omitted schedules upon request by the SEC.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
